Dec 14 (Reuters) - Milestone Scientific Inc MLSS.A
* Intends to provide additional data in consultation with
FDA Co's Compu-Flo intra articular computer controlled
injection system
* Received notification from FDA that Co did not adequately
document that device met equivalency standard required for
510(k) clearance
* Cost to generate incremental data estimated to be
approximately $100,000
* Provides regulatory update
Source text for Eikon: ID:nMKWbmGy2a
Further company coverage: MLSS.A
((Bangalore.newsroom@thomsonreuters.com;))